- $2 BnWorld market, 2023
- $3.8 BnProjected, 2033
- 6.5%Growth a year (CAGR)
- –Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$840 Mn
4.5% a year · 42% of the world -
2
China
$161 Mn
8% a year · 8% of the world -
3
Canada
$160 Mn
6.5% a year · 8% of the world -
4
Japan
$124 Mn
7% a year · 6.2% of the world -
5
Germany
$73 Mn
4.7% a year · 3.7% of the world -
6
France
$55 Mn
5.5% a year · 2.8% of the world -
7
UK
$52 Mn
4.5% a year · 2.6% of the world -
8
Brazil
$50 Mn
7.5% a year · 2.5% of the world -
9
Italy
$48 Mn
6% a year · 2.4% of the world -
10
Ecuador
$40 Mn
7.1% a year · 2% of the world
Iron Supplement by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $2 Bn | $3.8 Bn | 6.5% | – | – | Report on Iron Supplement in Global |
| North America | $1 Bn | $1.7 Bn | 5.5% | 50% | – | Report on Iron Supplement in North America |
| APAC | $420 Mn | $888 Mn | 7.8% | 21% | – | Report on Iron Supplement in APAC |
| Europe | $380 Mn | $633 Mn | 5.2% | 19% | – | Report on Iron Supplement in Europe |
| Latin America | $90 Mn | $186 Mn | 7.5% | 4.5% | – | Report on Iron Supplement in Latin America |
| Middle East | $80 Mn | $165 Mn | 7.5% | 4% | – | Report on Iron Supplement in Middle East |
| Africa | $30 Mn | $65 Mn | 8% | 1.5% | – | Report on Iron Supplement in Africa |
| US |
$840 Mn | $1.3 Bn | 4.5% | 42% | – | Report on Iron Supplement in US |
| China |
$161 Mn | $347 Mn | 8% | 8% | – | Report on Iron Supplement in China |
| Canada |
$160 Mn | $300 Mn | 6.5% | 8% | – | Report on Iron Supplement in Canada |
| Japan |
$124 Mn | $245 Mn | 7% | 6.2% | – | Report on Iron Supplement in Japan |
| Germany |
$73 Mn | $116 Mn | 4.7% | 3.7% | – | Report on Iron Supplement in Germany |
| France |
$55 Mn | $94 Mn | 5.5% | 2.8% | – | Report on Iron Supplement in France |
| UK |
$52 Mn | $81 Mn | 4.5% | 2.6% | – | Report on Iron Supplement in UK |
| Brazil |
$50 Mn | $103 Mn | 7.5% | 2.5% | – | Report on Iron Supplement in Brazil |
| Italy |
$48 Mn | $86 Mn | 6% | 2.4% | – | Report on Iron Supplement in Italy |
| Ecuador |
$40 Mn | $80 Mn | 7.1% | 2% | – | Report on Iron Supplement in Ecuador |
 Spain |
$39 Mn | $66 Mn | 5.5% | 1.9% | – | Report on Iron Supplement in Spain |
 India |
$36 Mn | $90 Mn | 9.5% | 1.8% | – | Report on Iron Supplement in India |
 Saudi Arabia |
$34 Mn | $73 Mn | 8% | 1.7% | – | Report on Iron Supplement in Saudi Arabia |
 Mexico |
$30 Mn | $58 Mn | 6.8% | 1.5% | – | Report on Iron Supplement in Mexico |
 Australia |
$24 Mn | $52 Mn | 8% | 1.2% | – | Report on Iron Supplement in Australia |
 South Africa |
$13 Mn | $27 Mn | 7.7% | 0.7% | – | Report on Iron Supplement in South Africa |
 UAE |
$10 Mn | $21 Mn | 7.5% | 0.5% | – | Report on Iron Supplement in UAE |
 Egypt |
$6 Mn | $12 Mn | 8% | 0.3% | – | Report on Iron Supplement in Egypt |
 Philippines |
$4 Mn | $9 Mn | 7% | 0.2% | – | Report on Iron Supplement in Philippines |
 Hong Kong |
$3 Mn | $7 Mn | 7.5% | 0.2% | – | Report on Iron Supplement in Hong Kong |
 Malaysia |
$3 Mn | $6 Mn | 6.7% | 0.2% | – | Report on Iron Supplement in Malaysia |
 Singapore |
$2 Mn | $5 Mn | 7.1% | 0.1% | – | Report on Iron Supplement in Singapore |
 Thailand |
$2 Mn | $5 Mn | 6.8% | 0.1% | – | Report on Iron Supplement in Thailand |
 Kenya |
$1 Mn | $3 Mn | 7.6% | 0.1% | – | Report on Iron Supplement in Kenya |
 New Zealand |
– | – | – | – | – | Report on Iron Supplement in New Zealand |
 Russia |
– | – | – | – | – | Report on Iron Supplement in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 3,529 papers since 2021
- Early-Onset Primary Lymphedema as The Initial Manifestation of GATA2 Deficiency: A Case Report. Lymphology, 2026
- Prevalence, determinants, and urban-rural disparities in postnatal care service utilization within two days of birth among newborns in low- and middle-income countries: a mixed effect and decomposition analysis. BMC pediatrics, 2026
- Differential recovery of macrophage iron deficiency by oral iron formulations determines inflammation and autocrine hepcidin production in iron-deficiency anemia. HemaSphere, 2026
- Iron Supplementation Adherence and Satisfaction Among Adolescent Girls Following Point-of-Care Quality Improvement in an Indonesian Community Health Center Program: An Uncontrolled Pre-Post Study. Patient preference and adherence, 2026
- Prevalence of iron deficiency anaemia and associated factors among preterm infants aged 3-6 months attending clinics in Dodoma, Tanzania: a facility-based cross-sectional study. Frontiers in pediatrics, 2026
Patients: Anaemia in women 15–49
| Place | Value | Year |
|---|---|---|
| World | 15.6 | 2023 |
| Australia | 11.1 | 2023 |
| Brazil | 21.3 | 2023 |
| Canada | 14.0 | 2023 |
| China | 15.6 | 2023 |
| Ecuador | 20.2 | 2023 |
| Egypt | 32.7 | 2023 |
| France | 13.1 | 2023 |
| Germany | 14.0 | 2023 |
| India | 53.7 | 2023 |
| Italy | 16.4 | 2023 |
| Japan | 18.7 | 2023 |
| Kenya | 32.2 | 2023 |
| Malaysia | 31.3 | 2023 |
| Mexico | 13.2 | 2023 |
| New Zealand | 12.4 | 2023 |
| Philippines | 12.0 | 2023 |
| Russia | 24.1 | 2023 |
| Saudi Arabia | 17.6 | 2023 |
| Singapore | 16.6 | 2023 |
| South Africa | 31.2 | 2023 |
| Spain | 15.6 | 2023 |
| Thailand | 20.7 | 2023 |
| UAE | 28.2 | 2023 |
| UK | 13.6 | 2023 |
| US | 15.0 | 2023 |
Compare Iron Supplement side by side
Key companies in Iron Supplement
Pfizer Inc.
Nature’s Bounty
Pharmavite LLC
Ferro Corporation
GlaxoSmithKine plc
Solgar
Reckitt Benckiser Group plc
Amway
Quick answers
How big is the Iron Supplement market?
The world Iron Supplement market was worth about $2 Bn in 2023 and is projected to reach $3.8 Bn by 2033, growing 6.5% a year (CAGR).
Which country has the largest Iron Supplement market?
The US is the largest of the 24 countries we cover, at $840 Mn in 2023. India grows fastest, at 9.5% a year.
How much research is published on Iron Supplement?
PubMed lists about 3,529 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.